New Gamma Knife Perfects Treatment of Brain Tumors, Malformations

PRLog (Press Release)Apr 26, 2012

Based on the successful treatment of more than 1,000 patients since 2001 with Gamma Knife® radiosurgery, South Nassau Communities Hospital recently upgraded to the Gamma Knife Perfexion™.
The Gamma Knife Perfexion system is the latest advancement in noninvasive radiosurgery treatment of tumors and abnormalities in the brain.  South Nassau Communities Hospital was the first on Long Island to offer the Gamma Knife and is now the first on Long Island to offer the Gamma Knife Perfexion.
“The Gamma Knife proved to be of great benefit to the communities we serve because it enabled us to provide the premiere treatment for the array of life-threatening and serious brain diseases,” said Edward Mullen, MD, director of radiation oncology and co-medical director of the Long Island Gamma Knife® at South Nassau’s Gertrude & Louis Feil Cancer Center.  “Based on the patient outcomes and the community’s continued need for the technology, we acted quickly to upgrade to the new system.”
With the Gamma Knife Perfexion, South Nassau’s Gamma Knife team has the capability to treat a broad scope of disorders, including tumors at the base of the skull, lesions in the sinuses, eye socket and neck and multiple metastatic (cancerous) tumors, deep-seated tumors and tumors close to arteries, nerves or other vital structures.
The Gamma Knife Perfexion will also be used to treat benign tumors such as acoustic neuromas, meningiomas, and pituitary adenomas; functional disorders including trigeminal neuralgia; arteriovenous malformations; and other neurological conditions such as intractable cancer pain as well as essential tremors.
The Gamma Knife Perfexion delivers a single, precise, high dose of ionizing radiation deep into the brain to destroy the tumor or lesion while protecting healthy surrounding tissue.  The procedure can provide hope to patients for whom traditional brain surgery or radiation therapy are not options.
“Since Gamma Knife Perfexion surgery is non-invasive, the lengthy hospital stays associated with brain surgery are avoided,” said Michael Brisman, MD, co-medical director of the Long Island Gamma Knife.  “Patients return home the same day of treatment, and can usually resume their normal activities, including working and driving, the next day.”
There is little risk of potential morbidity, such as hemorrhage and infection, which are associated with conventional surgery.  More than 30 years of clinical studies documented in more than 2,500 published medical papers have revealed the effectiveness of Gamma Knife surgery.  Studies show that local control – meaning the specific tumor treated does not return – exceeds an average of 85% for the management of tumors in any brain location.
In addition to the Gamma Knife Perfexion, South Nassau’s Gertrude & Louis Feil Cancer Center is equipped with the Novalis Tx™ (which performs radiosurgery on a malignancy or benign lesion located anywhere in the body in a matter of minutes, and often in five or fewer treatment sessions) and the da Vinci® Surgical System (which helps surgeons perform complex surgeries with refined dexterity, precision and control, through small incisions).  The center is the only one on Long Island that is equipped with all of these technologies, which are three of the most advanced and effective at treating and eradicating cancer.
South Nassau Communities Hospital is one of the region’s largest hospitals, with 435 beds, more than 900 physicians and 2,900 employees.  Located in Oceanside, NY, the hospital is an acute-care, not-for-profit teaching hospital that provides state-of-the-art care in cardiac, oncologic, orthopedic, bariatric, pain management, mental health and emergency services.  In addition to its extensive outpatient specialty centers, South Nassau provides emergency and elective angioplasty and is the only hospital on Long Island with the Novalis Tx™ and Gamma Knife® Perfexion radiosurgery technologies.  South Nassau is a designated Stroke Center by the New York State Department of Health and Comprehensive Community Cancer Center by the American College of Surgeons and is recognized as a Bariatric Surgery Center of Excellence by the American Society for Metabolic and Bariatric Surgery.  For more information, visit www.southnassau.org.

Leksell Gamma Knife Perfexion - Upgrade Program

Date: 2012-08-22 to 2012-08-24
Calendar Link: Calendar Link
Location: Cleveland Clinic Gamma Knife Center, Cleveland, OH, United States
Description: Objective
To receive aspects of clinical and technical training for handling new features of Leksell Gamma Knife Perfexion, when upgrading from previous models. Training on the dynamic workflow of Leksell GammaPlan includes instruction on using the pre-planning and follow-up features of the program as well as on developing treatment plans using composite shots, dynamic shaping, and inverse-planning options.
 
Content
      System and workflow overview
      New approaches to treatment plans
      New features in Leksell GammaPlan
      Treatment using Leksell Gamma Knife Perfexion
      QA procedures
 
Training centers and duration
3-day course at Cleveland Clinic Gamma Knife Center, Cleveland, OH, USA
 
Target group
      Medical Physicists
      Neurosurgeons
      Radiation Oncologists
      Nurses
      Others responsible for the operation of Leksell Gamma Knife
Registration page: Click to get to Registration page
Contact E-Mail: education-neuro@elekta.com

Cleveland Clinic Gamma Knife Center Offers State-of-the-Art Alternative To Invasive Brain Tumor Surgery

Cleveland Clinic’s Gamma Knife® treatment combines state-of-the-art radiosurgery treatment technology with medical expertise to provide treatment solutions for the most complex brain tumor diagnoses.

Cleveland Clinic offers its state-of-the-art Gamma Knife Center, providing innovative brain tumor surgery alternatives to conventional, invasive brain surgery. Over the course of their illness, nearly 25% of cancer patients will develop a metastatic brain tumor. Patients who have developed tumors deep in the brain often cannot have these tumors removed safely by traditional brain surgery. Gamma Knife radiosurgery gives these patients comparable results to surgery, with the advantage of a minimally invasive procedure, requiring no incision.
Gamma Knife surgery delivers targeted radiation to the specific tumor location(s) in the brain. It is a safe, effective treatment that offers lower risk than conventional brain surgery and with low complication rate. Performed on an outpatient basis and rarely requiring an overnight stay, Gamma Knife surgery can also be a prescribed course of treatment in conjunction with other therapies such as chemotherapy, radiation or surgery. As one of the busiest and most experienced Gamma Knife centers in the country, having treated nearly 4,000 patients since opening in 1997, Cleveland Clinic Gamma Knife Center® is also one of a select group of medical centers that trains other physicians on this type of radiotherapy treatment.
The neurosurgeons, radiation oncologists and medical physicists at Cleveland Clinic offer a level of expertise that can dramatically affect patients’ outcomes: “It's not just the Gamma Knife itself; it's the physician using it that matters,” said Michael Vogelbaum, MD, PhD, Associate Director of Cleveland Clinic’s Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center.
“At the Burkhardt Brain Tumor Center we believe that access to multiple tools, along with the knowledge and experience to understand how best to use them to treat each individual patient, can make a difference in the length and quality of survival,” Dr. Vogelbaum said. “In the case of many of our Gamma Knife patients who have good systemic control of their disease, radiosurgery has its greatest impact on improving survival and on maintaining the ability to carry on a normal life,” said Dr. Vogelbaum.
Patients who undergo the Gamma Knife procedure experience little or no post-treatment discomfort or pain. They enjoy a rapid return to normal activities, without the need for physical therapy or other rehabilitation. Gamma Knife surgery is typically covered by most insurance companies and Medicare.
Prospective patients can view a Gamma Knife patient guide and video at http://www.clevelandclinic.org/gammaknifeinfo
About Cleveland Clinic
Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. It was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. U.S.News & World Report consistently names Cleveland Clinic as one of the nation’s best hospitals in its annual “America’s Best Hospitals” survey. About 2,800 full-time salaried physicians and researchers and 11,000 nurses represent 120 medical specialties and subspecialties. Cleveland Clinic health system includes a main campus near downtown Cleveland, eight community hospitals and 18 Family Health Centers in Northeast Ohio, as well as Cleveland Clinic Florida, the Lou Ruvo Center for Brain Health in Las Vegas, Cleveland Clinic Canada, and, opening in 2013, Cleveland Clinic Abu Dhabi. In 2011, there were 4.6 million visits throughout the Cleveland Clinic health system and 160,000 hospital admissions. Patients came for treatment from every state and from more than 100 countries. Visit us at http://www.clevelandclinic.org. Follow us at twitter.com/ClevelandClinic.
The information contained in this communication was developed by Cleveland Clinic's Marketing Department.
For more information about Cleveland Clinic’s Gamma Knife Center please contact:
Halle Bishop
Public Relations Manager
216.445.8592

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012gamma/03knife/prweb9307677.htm

Original Article: Cleveland Clinic Gamma Knife Center Offers State-of-the-Art Alternative To Invasive Brain Tumor Surgery

Printed From BioPortfolio.com + News Categories + Corporate Categories NEXT ARTICLE New Gamma Knife at South Nassau Communities Hospital Perfects Treatment of Brain Tumors, Malformations

Oceanside, NY, April 28, 2012 --(PR.com)-- Based on the successful treatment of more than 1,000 patients since 2001 with Gamma Knife® radiosurgery, South Nassau Communities Hospital recently upgraded to the Gamma Knife Perfexion™.

The Gamma Knife Perfexion system is the latest advancement in noninvasive radiosurgery treatment of tumors and abnormalities in the brain. South Nassau Communities Hospital was the first on Long Island to offer the Gamma Knife and is now the first on Long Island to offer the Gamma Knife Perfexion.

“The Gamma Knife proved to be of great benefit to the communities we serve because it enabled us to provide the premiere treatment for the array of life-threatening and serious brain diseases,” said Edward Mullen, MD, director of radiation oncology and co-medical director of the Long Island Gamma Knife® at South Nassau’s Gertrude & Louis Feil Cancer Center. “Based on the patient outcomes and the community’s continued need for the technology, we acted quickly to upgrade to the new system.”

With the Gamma Knife Perfexion, South Nassau’s Gamma Knife team has the capability to treat a broad scope of disorders, including tumors at the base of the skull, lesions in the sinuses, eye socket and neck and multiple metastatic (cancerous) tumors, deep-seated tumors and tumors close to arteries, nerves or other vital structures.

The Gamma Knife Perfexion will also be used to treat benign tumors such as acoustic neuromas, meningiomas, and pituitary adenomas; functional disorders including trigeminal neuralgia; arteriovenous malformations; and other neurological conditions such as intractable cancer pain as well as essential tremors.

The Gamma Knife Perfexion delivers a single, precise, high dose of ionizing radiation deep into the brain to destroy the tumor or lesion while protecting healthy surrounding tissue. The procedure can provide hope to patients for whom traditional brain surgery or radiation therapy are not options.

“Since Gamma Knife Perfexion surgery is non-invasive, the lengthy hospital stays associated with brain surgery are avoided,” said Michael Brisman, MD, co-medical director of the Long Island Gamma Knife. “Patients return home the same day of treatment, and can usually resume their normal activities, including working and driving, the next day.”

There is little risk of potential morbidity, such as hemorrhage and infection, which are associated with conventional surgery. More than 30 years of clinical studies documented in more than 2,500 published medical papers have revealed the effectiveness of Gamma Knife surgery. Studies show that local control – meaning the specific tumor treated does not return – exceeds an average of 85% for the management of tumors in any brain location.

In addition to the Gamma Knife Perfexion, South Nassau’s Gertrude & Louis Feil Cancer Center is equipped with the Novalis Tx™ (which performs radiosurgery on a malignancy or benign lesion located anywhere in the body in a matter of minutes, and often in five or fewer treatment sessions) and the da Vinci® Surgical System (which helps surgeons perform complex surgeries with refined dexterity, precision and control, through small incisions). The center is the only one on Long Island that is equipped with all of these technologies, which are three of the most advanced and effective at treating and eradicating cancer.

South Nassau Communities Hospital is one of the region’s largest hospitals, with 435 beds, more than 900 physicians and 2,900 employees. Located in Oceanside, NY, the hospital is an acute-care, not-for-profit teaching hospital that provides state-of-the-art care in cardiac, oncologic, orthopedic, bariatric, pain management, mental health and emergency services. In addition to its extensive outpatient specialty centers, South Nassau provides emergency and elective angioplasty and is the only hospital on Long Island with the Novalis Tx™ and Gamma Knife® Perfexion radiosurgery technologies. South Nassau is a designated Stroke Center by the New York State Department of Health and Comprehensive Community Cancer Center by the American College of Surgeons and is recognized as a Bariatric Surgery Center of Excellence by the American Society for Metabolic and Bariatric Surgery
Contact Information:
South Nassau Communities Hospital
Damian J. Becker
516-377-5370
Contact via Email
southnassau.org


Press Release Distributed by PR.com

Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta


Leading global provider of radiation therapy and radiosurgery systems joins Atlanta biomedical community

ATLANTA, April 26, 2012 /PRNewswire via COMTEX/ -- Elekta, a leading international technology and solutions provider for the treatment of cancer and brain disorders, is relocating its North America headquarters in 2012. Elekta's new HQ will be The Terraces in Atlanta's Central Perimeter business district. The company anticipates adding more than 100 new jobs over five years in the life sciences field, specifically in the medical device and healthcare IT sectors.
"Elekta's global influence in healthcare is increasing rapidly," says Elekta's President and CEO, Tomas Puusepp. "The move of our North America headquarters to Atlanta will support this trend and strengthen Atlanta's growing biomedical community."
Elekta will be a new asset in DeKalb County, according to Judy Turner, Chair, Development Authority of DeKalb County, Ga.
"Elekta is the type of innovative health care company that will add to the synergy of other life science assets already located in DeKalb County, such as the Centers for Disease Control and Emory Healthcare," she says. "The Development Authority of DeKalb County is very proud to be a partner with Elekta and is looking forward to their new facility in DeKalb County."
"Medical device companies such as Elekta represent a large proportion of our bioscience industry, so we're pleased Elekta has chosen to continue to grow and create jobs in Georgia," adds Chris Cummiskey, Commissioner of the Georgia Department of Economic Development. "We have terrific collaborations and research expertise in this area."
Elekta helps reinforce the fact that Atlanta is a leading location for international bioscience companies, according to Hans Gant, senior vice president of economic development for the Metro Atlanta Chamber.
"One of Atlanta's true strengths is having access to a highly talented workforce, which will help support the projected growth of Elekta's operations," he says.
"The expansion of Elekta's North American Headquarters is an excellent example of the partnership between the Georgia Department of Economic Development, Metro Atlanta Chamber, and the City of Dunwoody to cultivate new business for Georgia," said Economic Development Director Michael Starling. "Elekta is a true reflection of the state's and Dunwoody's strategy to recruit and grow world-class technology companies."
"The decision by Elekta to establish its North American headquarters in Dunwoody is the culmination of a truly collaborative and creative effort," said Jeff Estep, executive managing director of Newmark Knight Frank, the consultant to Elekta. "We conducted a thorough analysis of Elekta's needs and location options across North America, including in-depth review of business costs, talent availability, training and operational processes, and the Atlanta area proved itself to be the ideal location for the company's global growth objectives. We received incredible support from the State of Georgia, DeKalb County, the City of Dunwoody and the Metro Atlanta Chamber."
Elekta develops sophisticated tools and dose planning systems for radiation therapy and radiosurgery and brachytherapy, in addition to software systems that improve the efficiency of workflows throughout the spectrum of cancer care. Among its most recognized products are Elekta Synergy®, Elekta Infinity(TM) and Elekta Axesse(TM) radiation treatment systems (linear accelerators), Leksell Gamma Knife® Perfexion(TM) radiosurgery system for ultra-precise treatment of intracranial disease targets, MOSAIQ® oncology information system and Monaco® treatment planning system.
Employing about 3,300 people globally, Elekta markets its solutions in North and South America, Europe, the Middle East, Africa and Asia-Pacific countries.
For further information, please contact:
Stina Thorman, Vice President Corporate Communications, Elekta AB Tel: +46 8 587 254 37, email: stina.thorman@elekta.com Time zone: CET: Central European Time
Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta Tel: +1 770-670-2447, email: michelle.joiner@elekta.com Time zone: ET: Eastern Time
About ElektaElekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com .


SOURCE Elekta

Elekta, Inc. to bring its headquarters to Dunwoody

Yet another international leader has chosen Dunwoody as the location for its North American headquarters. Elekta Inc., a leading international technology and solutions provider for the treatment of cancer and brain disorders, will be moving into The Terraces office complex, a 50,000-square-foot space. Elekta plans to bring in more than 100 new jobs over five years, particularly in the medical device and healthcare IT fields. The company also plans to relocate about 150 current employees from Norcross to Dunwoody. In addition, they are exploring plans to create a training center, which could take up an additional 20,000 square feet.
Lighthouse Inn 300x301 rail middle 1 (fp) rail-top 3 (ros) mobile in-story
“The expansion of Elekta’s North American Headquarters is an excellent example of the partnership between the Georgia Department of Economic Development, Metro Atlanta Chamber, and the City of Dunwoody to cultivate new business for Georgia,” said Economic Development Director Michael Starling. “Elekta is a true reflection of the state’s and Dunwoody’s strategy to recruit and grow world-class technology companies.”
Elekta develops sophisticated tools and dose planning systems for radiation therapy, radiosurgery and brachytherapy, in addition to software systems that improve the efficiency of workflows throughout the spectrum of cancer care.
Among its most renowned products are Elekta Synergy®, Elekta Infinity™ and Elekta Axesse™ radiation treatment systems (linear accelerators), Leksell Gamma Knife® Perfexion™ radiosurgery system for ultra-precise treatment of intracranial disease targets, MOSAIQ® oncology information system and Monaco® treatment planning system.
Elekta Inc. employs about 3,300 people globally and markets in North and South America, Europe, the Middle East, Africa and Asia-Pacific countries.
The company is the second this year to move its headquarters to Dunwoody. In March, CHEP, an international leader in pallet and container leasing, leased over 60,000 square feet of office space within the Hammond Exchange building.

American Shared Hospital Services: Can A Gamma Knife Generate Alpha?

American Shared Hospital Services (AMS) provides radiosurgery and radiation therapy equipment to 23 medical centers in seventeen states as well as Turkey, Peru and Brazil. The company owns an 81% interest in GK Financing, LLC which finances this equipment for these medical centers. The remaining 19% interest is held indirectly by Elekta AG, the Swedish manufacturer of the equipment, known as the Gamma Knife. Unfortunately, despite this relationship, AMS does not have exclusivity in any region on the Gamma Knife and has lost financing contracts in the past to third party financing companies as well as to Elektra itself.
When a medical facility wants a Gamma Knife, AMS (via GK Financing) pays for the equipment and ongoing maintenance costs and the medical facility pays for the renovations and installation costs. AMS then earns either a flat fee per use (approximately $7,500 - $9,500) of the machine or shares revenue with the medical facility.

Read More

New Gamma Knife at South Nassau Communities

Based on the successful treatment of more than 1,000 patients since 2001 with Gamma Knife® radiosurgery, South Nassau Communities Hospital recently upgraded to the Gamma Knife Perfexion™.

The Gamma Knife Perfexion system is the latest advancement in noninvasive radiosurgery treatment of tumors and abnormalities in the brain. South Nassau Communities Hospital was the first on Long Island to offer the Gamma Knife and is now the first on Long Island to offer the Gamma Knife Perfexion.

“The Gamma Knife proved to be of great benefit to the communities we serve because it enabled us to provide the premiere treatment for the array of life-threatening and serious brain diseases,” said Edward Mullen, MD, director of radiation oncology and co-medical director of the Long Island Gamma Knife® at South Nassau’s Gertrude & Louis Feil Cancer Center. “Based on the patient outcomes and the community’s continued need for the technology, we acted quickly to upgrade to the new system.”

With the Gamma Knife Perfexion, South Nassau’s Gamma Knife team has the capability to treat a broad scope of disorders, including tumors at the base of the skull, lesions in the sinuses, eye socket and neck and multiple metastatic (cancerous) tumors, deep-seated tumors and tumors close to arteries, nerves or other vital structures.

The Gamma Knife Perfexion will also be used to treat benign tumors such as acoustic neuromas, meningiomas, and pituitary adenomas; functional disorders including trigeminal neuralgia; arteriovenous malformations; and other neurological conditions such as intractable cancer pain as well as essential tremors.

The Gamma Knife Perfexion delivers a single, precise, high dose of ionizing radiation deep into the brain to destroy the tumor or lesion while protecting healthy surrounding tissue. The procedure can provide hope to patients for whom traditional brain surgery or radiation therapy are not options.

“Since Gamma Knife Perfexion surgery is non-invasive, the lengthy hospital stays associated with brain surgery are avoided,” said Michael Brisman, MD, co-medical director of the Long Island Gamma Knife. “Patients return home the same day of treatment, and can usually resume their normal activities, including working and driving, the next day.”

There is little risk of potential morbidity, such as hemorrhage and infection, which are associated with conventional surgery. More than 30 years of clinical studies documented in more than 2,500 published medical papers have revealed the effectiveness of Gamma Knife surgery. Studies show that local control – meaning the specific tumor treated does not return – exceeds an average of 85% for the management of tumors in any brain location.

In addition to the Gamma Knife Perfexion, South Nassau’s Gertrude & Louis Feil Cancer Center is equipped with the Novalis Tx™ (which performs radiosurgery on a malignancy or benign lesion located anywhere in the body in a matter of minutes, and often in five or fewer treatment sessions) and the da Vinci® Surgical System (which helps surgeons perform complex surgeries with refined dexterity, precision and control, through small incisions). The center is the only one on Long Island that is equipped with all of these technologies, which are three of the most advanced and effective at treating and eradicating cancer.

South Nassau Communities Hospital is one of the region’s largest hospitals, with 435 beds, more than 900 physicians and 2,900 employees. Located in Oceanside, NY, the hospital is an acute-care, not-for-profit teaching hospital that provides state-of-the-art care in cardiac, oncologic, orthopedic, bariatric, pain management, mental health and emergency services. In addition to its extensive outpatient specialty centers, South Nassau provides emergency and elective angioplasty and is the only hospital on Long Island with the Novalis Tx™ and Gamma Knife® Perfexion radiosurgery technologies. South Nassau is a designated Stroke Center by the New York State Department of Health and Comprehensive Community Cancer Center by the American College of Surgeons and is recognized as a Bariatric Surgery Center of Excellence by the American Society for Metabolic and Bariatric Surgery.

Gamma Knife Radiosurgery in the Treatment of Tumor-Related Facial Pain.


Source

Department of Radiation Oncology, Wake Forest University, Winston-Salem, N.C., USA.

Abstract

Background: Intracranial neoplasms can cause pain similar to trigeminal neuralgia. Literature regarding radiosurgery for this is limited. We present a retrospective review of patients with tumor-related facial pain from benign lesions treated with gamma knife radiosurgery (GKRS) at Wake Forest University. Objectives: The primary objectives were to determine long-term pain relief and predictive factors for pain alleviation. Methods: We reviewed 515 patients treated with GKRS for benign meningioma, vestibular schwannoma or trigeminal schwannoma between August 1999 and August 2010. Twenty-one eligible patients had tumor-related facial pain prior to GKRS.

Read More

Elekta to Unveil New Neuroscience Solution for Leksell Gamma Knife at 2012 AANS Meeting

PR Newswire
MIAMI BEACH, Fla., April 13, 2012 /PRNewswire/ -- At the 2012 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting, April 14-18, at the Miami Beach Convention Center, Elekta (booth #725) will reveal compelling innovations for Leksell Gamma Knife® Perfexion™ that promise to enhance information management.
"Once again, AANS will give us the opportunity to demonstrate to neurological surgeons that Gamma Knife® radiosurgery is a continually evolving technique that makes use of the technological expertise that Elekta has gained over the last 60 years," says Jay Hoey, Executive Vice President, Elekta North America. "The latest example is the capability to exchange information, such as treatment plans, treatment record and protocols, both pre- and post-treatment, putting electronic medical records at your fingertips and allowing you to see all of your treatment statistics in one convenient dashboard. The result is a better flow of patient care and improved use of time and resources."
In addition to the latest product enhancements, Elekta will highlight characteristics of Leksell Gamma Knife Perfexion that separate the system from other radiosurgery solutions. These include its dedication to intracranial cases, complete solution integration, industry-leading accuracy, "shrink-wrap" dose conformity and extensive proven clinical efficacy. Demonstrations of the system will emphasize that Perfexion is designed to minimize the risk of human error and radiation toxicity, while optimizing accuracy and dose conformance.
Other meeting highlightsElekta also will exhibit several other solutions that improve the management of neurological and neurosurgical cases, including:
  • Extend™ System for frameless, multi-session hypofractionation Gamma Knife radiosurgery
  • Elekta Neuromag® TRIUX, the most highly sophisticated magnetoencephalography (MEG) system available
  • Leksell Stereotactic System® for functional neurosurgery. Exceptional imaging, high platform rigidity and ease of use ensure that critical accuracy requirements are met for this surgical discipline
  • Leksell SurgiPlan® 10, Elekta's advanced image-based neurosurgical planning software specifically designed for Leksell Stereotactic System®
About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.

SOURCE Elekta

If you have any query regarding Gamma Knife Radiosurgery you can contact us

There was an error in this gadget
gammaknifeinfo.blogspot.com is a web directory which guides you to find out websites related with all gamma knife centre, gamma knife hospital, journals, gamma knife lectures, gamma knife e books, gamma knife videos,gamma knife forums,...etc. To help others in gamma knife related website or link please contribute Email me .